The Project Review Committee (PRC) consists of up to 11 members, both academic researchers and relevant companies. The PRC reviews and rates all abstracts as well as non-anonymised full-length applications. They then nominate projects to the Steering Group. Academic PRC members may not apply as main applicants in a Grant Type 1 call round while sitting on the committee.
You can read more about the review organs on our website or contact us for more information.
Mark Denham, AU
Senior Researcher, Department of Molecular Medicine, Aarhus University Hospital; Co-founder, UniPotent Therapeutics
Karen Dybkær Sørensen, AAU
Professor, Department of Clinical Medicine, Aalborg University; Department of Hematology, Aalborg University Hospital
Thomas Emil Andersen, SDU
Professor, Department of Clinical Microbiology
Jørn Bolstad Christensen, KU
Associate Professor, Department of Chemistry
Andrew Urquhart, DTU
Associate Professor, Department of Health Technology
Sebastian Beck Jørgensen, Novo Nordisk
Scientific Director, R&D External Innovation, Scientific Partnerships & Integration
Karina Fog, H. Lundbeck
Senior Director, Biology Lead Protein Aggregation, Folding & Clearance, Neuroscience
Asha Seth, AstraZeneca
Director
ABOUT ODIN
ODIN brings researchers from academia and industry together to co-create need-driven research projects that can lead to new treatments, diagnostics, tools, and technologies. We fund the strongest project ideas through competitive funding calls. Companies cannot receive ODIN funding, but participation is free of charge and gives access to academic expertise, new collaborations, and opportunities to explore early-stage research challenges.
ODIN is supported by the Novo Nordisk Foundation and the Lundbeck Foundation.
CONTACT ODIN
You are welcome to contact us if you have questions or comments. Reach out to odin@au.dk.
Although the platform spans five Danish universities, we're based in Aarhus. Our office is located at Aarhus University, Ny Munkegade 116, Bldg 1535-117.
